Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,806 0% |
 |
Gilead SciencesGILD |
77,667 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,752 0% |
 |
Inovio PharmaceuticalsINO |
92,335 0% |
 |
Anavex Life SciencesAVXL |
24,167 0% |
Hoth Therapeutics Stocktwits Subscriber Count
Hoth Therapeutics (HOTH) has 11,583 subscribers on Stocktwits, roughly flat (+0.0%) over the past three months.
With 11,583 subscribers, Hoth Therapeutics has a smaller Stocktwits following than Amgen (14,806) and Gilead Sciences (77,667).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How HOTH’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking HOTH. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Hoth Therapeutics’s Stocktwits community into the HOTH AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see HOTH Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Hoth Therapeutics Stocktwits Subscribers: Frequently Asked Questions
Hoth Therapeutics (HOTH) has 11,583 subscribers (12K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Hoth Therapeutics's Stocktwits subscriber base has been roughly flat (+0.0%) over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines HOTH’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Hoth Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 8th percentile.
Sign up and get more insights on Hoth Therapeutics.
See Hoth Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for HOTH — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
